Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TUBB2B | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | LDOC1L | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | SSPO | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | SLC8A2 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | KIF1C | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | FAM3B | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | PCDHA8 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | MAP2 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | CERKL | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | GLT1D1 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |